Michael Lee Milligan
Title: Chief Financial Officer & Principal Accounting Officer · 2 filings · Latest: Aug 20, 2026
Neumora Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NMRA | Michael Lee Milligan | Title: Chief Financial Officer & Principal Accounting Officer | Feb 17, 2026 | Sale | $3.57 | 1,436 | $5.1K | 21,034 | |
NMRA | Milligan Michael Lee | — | Feb 17, 2026 | Proposed Sale | $3.57 | 1,436 | $5.1K | — | |
NMRA | Milligan Michael Lee | — | Feb 18, 2025 | Proposed Sale | $1.69 | 1,978 | $3.4K | — |